Description
ApnatĀ 60 mg consists of Apalutamide as its active ingredient. It is an anti-cancer drug that belongs to the androgen receptor inhibitors class of medications. It is indicated for treating patients with certain types of prostate cancer whose cancer has spread to other parts of the body and still responds to a medical or surgical treatment that lowers testosterone (male reproductive hormone) or whose cancer has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone.
ApnatĀ 60 mg works by stopping the effects of androgen (male reproductive hormone) from stopping the growth or spread of cancer cells. Inform your physician if you have any symptoms of chest pain, indigestion, heart attack, trouble walking, and numbness in the face and body. It is not recommended for pregnant women because this may cause harm to their unborn baby. This medication may be taken with or without food. This medicine may cause fertility problems in males. Males should not become fathers or donate sperm during the treatment and for 3 months after the last done.Ā Use effective birth control methods.
Uses ofĀ Apnat 60mg Tablet
- Metastatic castration-sensitive prostate cancer.
- Non-metastatic castration-resistant prostate cancer.
Therapeutic Effects ofĀ Apnat 60mg Tablet
ApnatĀ 60 mg is a selective androgen receptor (AR) inhibitor that binds directly to the androgen receptor binding domain. It inhibits protein transportation in the nucleus, DNA binding, and AR-mediated transcription. Treatment with this medicine reduces cancer cell growth and increases cell death, resulting in effective anticancer activity.
Reviews
There are no reviews yet.